➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
AstraZeneca
Mallinckrodt
Boehringer Ingelheim
Medtronic

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Litigation Details for IN RE ACTOS END PAYOR ANTITRUST LITIGATION (S.D.N.Y. 2013)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

IN RE ACTOS END PAYOR ANTITRUST LITIGATION (S.D.N.Y. 2013)

Docket   Start Trial Date Filed 2013-12-31
Court District Court, S.D. New York Date Terminated
Cause 28:1332bc Diversity-Breach of Contract Assigned To Ronnie Abrams
Jury Demand Plaintiff Referred To Stewart D. Aaron
Parties 199 SEIU-NATIONAL BENEFIT FUND; A.F. OF L. - A.G.C. BUILDING TRADES WELFARE PLAN; ACTAVIS PLC; ALL PLAINTIFFS; AMERICAN SALES COMPANY, LLC; CESAR CASTILLO, INC.; CITY OF PROVIDENCE, RHODE ISLAND; CROSBY TUGS, LLC; DENNIS KREISH; FRATERNAL ORDER OF POLICE, FORT LAUDERDALE LODGE 31, INSURANCE TRUST FUND; GREATER METROPOLITAN HOTEL EMPLOYERS-EMPLOYEES HEALTH AND WELFARE FUND; INTERNATIONAL UNION OF OPERATING ENGINEERS LOCAL 132 HEALTH AND WELFARE FUND; LOCAL 17 HOSPITALITY BENEFIT FUND; MAN-U SERVICE CONTRACT TRUST FUND; MINNESOTA AND NORTH DAKOTA BRICKLAYERS AND ALLIED CRAFTWORKERS HEALTH FUND; MYLAN PHARMACEUTICALS INC.; MYLAN, INC.; NECA-IBEW WELFARE TRUST FUND; NEW ENGLAND ELECTRICAL WORKERS BENEFIT FUND; PAINTERS DISTRICT COUNCIL NO. 30 HEALTH AND WELFARE FUND; PLUMBERS & PIPEFITTERS LOCAL 178 HEALTH & WELFARE TRUST FUND; RANBAXY INC.; RANBAXY LABORATORIES, LTD.; RANBAXY PHARMACEUTICALS INC.; RANBAXY PHARMACEUTICALS, INC.; RANBAXY, INC.; TAKEDA AMERICA HOLDINGS, INC.; TAKEDA DEVELOPMENT CENTER AMERICAS, INC.; TAKEDA PHARAMCEUTICALS, U.S.A., INC.; TAKEDA PHARMACEUTICAL COMPANY LIMITED; TEAMSTERS UNION LOCAL 115 HEALTH & WELFARE FUND; TEVA PHARMACEUTICAL INDUSTRIES, LTD.; TEVA PHARMACEUTICALS USA, INC.; UNITED FOOD AND COMMERCIAL WORKERS LOCAL 1776 & PARTICIPATING EMPLOYERS HEALTH AND WELFARE FUND; WATSON LABORATORIES, INC.
Patents 6,329,404
Attorneys Adam G. Kurtz; Adam R Lawton; Alex Rafael Straus; ALL PLAINTIFFS; Andrea B. Bierstein; Brian James Robbins; Brian O. O'Mara; Brian Philip Murray; Christina H. C. Sharp; Craig Eldon Bolton; Dan Drachler; Daniel Charles Girard; David S. Nalven; David W. Mitchell; Derek Y. Brandt; Devin Allan Debacker; Domenico George Minerva; Donna M. Evans; Elizabeth G. Arthur; Frank Rocco Schirripa; Garrett D. Blanchfield , Jr.; Gary B. Friedman; Gregory Bradley Linkh; Gregory E. Del Gaizo; Gregory L. Skidmore; Jay Philip Lefkowitz; Jayne Arnold Goldstein; Jeffrey C. Bank; Jeffrey Ira Weinberger; Jessica Leigh Margolis; John Andrew Ioannou; John Anthony Kehoe; John Douglas Richards; John O'Quinn; Jonathan Lutinski; Joseph Serino , JR.; Justin N Boley; Kara A. Elgersma; Karen Hoffman Lent; Karen M. Leser-Grenon; Katherine R. Katz; Kellie Marie Kemp; Kenneth A. Wexler; Kevin A. Seely; Kolin C. Tang; Laurie Rubinow; Lee Albert; Lori Ann Fanning; Mark Goldstein; Marvin Alan Miller; Matthew Weiner; Michael Morris Buchman; Mitchell Mark Breit; Natalie Finkelman Bennett; Peter George Safirstein; Richard L. Coffman; Rohit K. Singla; Ross Lee Weiner; Samuel Howard Rudman; Scott H. Levy; Scott M Grzenczyk; Seth C. Silber; Sharon Kunjumon Robertson; Stacey Anne Mahoney; Steve D. Shadowen; Steven Craig Sunshine; Stewart L. Cohen; Thane D. Scott; Tracey Kitzman; Valentina V. Rucker
Firms Cohen Milstein Sellers & Toll PLLC; Cohen, Placitella & Roth; Friedman Law Group LLP; Girard Gibbs; Girard Gibbs LLP; Glancy Binkow & Goldberg LLP (NYC2); Glancy Binkow Goldberg LLP; Glancy Prongay and Murray LLP; Hach Rose Schirripa & Cheverie LLP; Hagens Berman Sobol Shapiro LLP (MA); Hanly Conroy Bierstein Sheridan Fisher & Hayes LLP; Hilliard & Shadowen LLP; Hilliard Shadowen, LLP; Kirkland & Ellis LLP; Kirkland & Ellis LLP - NYC; Kirkland and Ellis LLP (Washington); McCune Wright Arevalo, LLP; Milberg Tadler Phillips Grossman LLP (NYC); Miller Law LLC; Morgan & Morgan, P.C.; Morgan, Lewis and Bockius LLP (NY); Motley Rice LLC-NY; Munger, Tolles & Olson (LA); Munger, Tolles & Olson LLP; Munger, Tolles & Olson LLP (SF); Pomerantz LLP; Reinhardt, Wendorf & Blanchfield; Robbins Arroyo LLP; Robbins Geller Rudman & Dowd LLP-San Diego; Robbins Geller Rudman & Dowd LLP(LI); Robbins Umeda LLP; Safirstein Metcalf LLP; Shepherd Finkelman Miller & Shah LLP; Shepherd, Finkelman, Miller & Shah, LLC; Skadden, Arps, Slate, Meagher & Flom LLP (DC); The Coffman Law Firm; Wexler Toriseva Wallace LLP; Wexler Wallace LLP; Wilson Sonsini Goodrich & Rosati; Wilson Sonsini Goodrich & Rosati (NYC); Wilson Sonsini Goodrich & Rosati(NYC); Wilson Sonsini Goodrich and Rosati; Zwerling, Schachter & Zwerling, LLP (Seattle)
Link to Docket External link to docket
Small Molecule Drugs cited in IN RE ACTOS END PAYOR ANTITRUST LITIGATION
The small molecule drugs covered by the patent cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for IN RE ACTOS END PAYOR ANTITRUST LITIGATION (S.D.N.Y. 2013)

Date Filed Document No. Description Snippet Link To Document
2015-09-22 221 (“584 patent”) and 6,329,404 (“404 patent”). 'l`he 584 and 404 patents also claimed methods of using…submitted patent information for the 584 and 404 patents, describing them as drug product patents claiming…the 584 and 404 patents in the Orange Book as “drug product patents” because those patents did “not claim…brand’s patents. Any ANDA submitted must contain “an appropriate certification for each listed patent.” 21…product Where there are no applicable patents, or the patents have expired or will expire prior to the External link to document
2018-03-14 255 and 6,329,404 (the “’404 Patent”)—claim the ACTOS drug product. These patents plainly and unambiguously…its patent information that the two patents—United States Patent Nos. 5,965,584 (the “’584 Patent”) and…the ’777 Patent, the ’584 Patent, and the ’404 Patent, Takeda submitted eight other patents to the FDA…the ’584 Patent and the ’404 Patent as drug- product patents claiming ACTOS only if the patents in fact…improper patent information describing the ’584 Patent and ’404 Patent as drug product patents for ACTOS External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Moodys
Baxter
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.